Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
28 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsZealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
(WorldNews Denmark)

 
 

18 september 2018 15:56:45

 
Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
(WorldNews Denmark)
 


Company announcement - No. 23/2018 Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia All primary and key secondary endpoints successfully achieved 99% of patients on dasiglucagon recovered from low blood glucose within 15 minutes Median time to plasma glucose recovery of 10 minutes with dasiglucagon Conference call today, September 18 at 5 PM CET/11 AM ET Copenhagen, September 18, 2018 - Zealand Pharma A/S (`Zealand`) (Nasdaq: ZEAL), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the successful results in the pivotal Phase 3 trial...


 
9 viewsCategory: General > Europe > Denmark
 
Danish producer saves 75 tonnes of `ugly` tomatoes
(WorldNews Denmark)
What next for broadcaster DR after far-reaching cuts?
(WorldNews Denmark)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten